NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
← HGH vendors

Shandong Aishi BiotechnologyHGH

3 testslatest 3 Aug 2026
Peptide testing

Ordered HGH from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
+2 more ↓
38%
Finnrick rating
#4 of 5 HGH vendors
1 of 3 classifiable tests passed
natural 33%
methodology · Purity focus
Finnrick analysis · HGH

Shandong Aishi Biotechnology's purity-focus evidence is strongest for GHK-Cu, where recent identity-confirmed lots show high purity and clearer batch IDs, while Ipamorelin is positive but short. Retatrutide has slipped from a stronger spring run into recent purity misses, and Tesamorelin remains dispersed on fill despite a latest-lot rebound.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shandong Aishi Biotechnology

Corporate records tie Aishi to a real Dezhou entity, but registry data and storefront claims conflict over staff, licences and factory capacity. The report maps a dead canonical domain, replacement sales funnels, shared COAs and a near-name buyer-confusion risk.

32 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
94%
16
2
Tirzepatide
$0.43
81%
31
3
Retatrutide
$0.93
76%
26
4
Ipamorelin
$1.96
74%
4
5
BPC-157
-
56%
3
6
Tesamorelin
$2.10
46%
7
7
HGHselected
-
38%
3
8
Cagrilintide
$4.40
-
0
9
MOTS-c
-
-
0
10
Semaglutide
$0.65
-
0
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%15 Jun 2026: 35%3 Aug 2026: 36%3 Aug 2026: 39%12 Nov 2026: current 38%35%38%Jun 26Nov 26
Showing HGH tests only
Shandong Aishi Biotechnology HGH test history
COA-backed lab tests

About Shandong Aishi Biotechnology test results from Finnrick

Shandong Aishi Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 90 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shandong Aishi Biotechnology peptides in this dataset are BPC-157 (3 tests), GHK-Cu (16 tests) and HGH (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 90 recent tests.

Corrections
No corrections.
Peptide testing

Ordered HGH from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply